COMP <GO>
NAGE vs GLAS // EV/EBITDA & P/E VALUATION
Niagen Bioscience Inc. (NASDAQ) VS. Glass House Brands Inc. Subordinate Voting Shares (NYSE) • 15-METRIC TALLY: NAGE 9
— GLAS 1
■ METRIC PARITY
LAST: $2.50 (-1.57%) • MKT CAP: $197.8M
valuation
12.2x
LAST: $2.28 (+1.33%) • MKT CAP: $200.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NAGE VS. GLAS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NAGE | GLAS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.30% | 42.30% | +22.00 | NAGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.80% | -9.20% | +26.00 | NAGE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.2x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 6.83% | -7.84% | +14.67 | NAGE | /fcf-yield <GO> |
| Operating Margin | 12.60% | -9.10% | +21.70 | NAGE | /operating-margins <GO> |
| Net Profit Margin | 13.40% | -16.30% | +29.70 | NAGE | /net-margins <GO> |
| Revenue Growth (YoY) | 29.90% | -9.40% | +39.30 | NAGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.40 | 0.38 | +4.02 | NAGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | NAGE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 13.8 | +29.07 | NAGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $197.8M | $200.6M | -$2.8M | GLAS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NAGE REV | GLAS REV | NAGE GROSS % | GLAS GROSS % | NAGE FCF | GLAS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.4M | $182.0M | 64.3% | 42.3% | $13.5M | -$15.7M |
| FY 2024 | $99.6M | $200.9M | 61.8% | 48.5% | $12.1M | $18.1M |
| FY 2023 | $83.6M | $160.8M | — | — | $7.1M | $23.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NAGE // BETA —
GLAS // BETA —